An experimental vaccine teaching patients’ immune systems to identify and attack cancer cells could help women diagnosed with ...

An international, Phase III clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare ...

Top-line data for its phase 2b trial studying GH001 is expected either in the fourth quarter of 2024 or the first quarter of ...

Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the ...

There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to ...

Medable is bringing generative AI into its clinical trial platform in hopes that the tech will reduce the burden of ...

In this week’s episode of “Podnosis,” we’re diving deep into the current landscape of clinical trials in the U.S.

In Japan, clinical use is climbing faster, with about 4,500 people now on the drug. ARIA rates in Japan are half those in the U.S., which was also the case in the Phase 3 Clarity trial. Meanwhile, use ...

A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer. Siteman Cancer ...

Mauro highlighted the need for a balanced approach, integrating both real-world data and clinical trial evidence to optimize ...